Arthur Greenberg.

Bradley S. Dixon, M http://aygestin.org/the-birth-control-mechanism-of-aygestin-norethisterone.html .D., Gerald J. Beck, Ph.D., Miguel A. Vazquez, M.D., Arthur Greenberg, M.D., James A. Delmez, M.D., Michael Allon, M.D., Laura M. Dember, M.D., Jonathan Himmelfarb, M.D., Jennifer J. Gassman, Ph.D., Tom Greene, Ph.D., Milena K. Radeva, M.S., Ingemar J. Davidson, M.D., T. Alp Ikizler, M.D., Gregory L. Braden, M.D., Andrew Z. Fenves, M.D., James S. Kaufman, M.D., James R. Cotton, Jr., M.D., Kevin J. Martin, M.D., James W. McNeil, M.D., Asif Rahman, M.D., Jeffery H.

Bengt C.D., Ph.D., Alan G. Jardine, M.D., Roland E. Schmieder, M.D., Hallvard Holdaas, M.D., Ph.D., Kym Bannister, M.D., Jaap Beutler, M.D., Ph.D., Dong-Wan Chae, M.D., Ph.D., Alejandro Chevaile, M.D., Stuart M. Cobbe, M.D.D., Ph.D. De Lima, M.D., Ph.D., Robert Lins, M.D., Ph.D., Gert Mayer, M.D., Alan W. McMahon, M.D., Hans-Henrik Parving, M.D., D.M.Sc., Giuseppe Remuzzi, M.D., Ola Samuelsson, M.D., Ph.D., Sandor Sonkodi, M.D., Ph.D., D. Sci.D., Dimitrios Tsakiris, M.D., Ph.D., Vladimir Tesar, M.D., Ph.D., Vasil Todorov, M.D., Ph.D., Andrzej Wiecek, M.D., Ph.D., Rudolf P.D., Mattis Gottlow, M.Sc., Eva Johnsson, M.D., Ph.D., and Faiez Zannad, M.D., Ph.D. For the AURORA Research Group: Rosuvastatin and Cardiovascular Occasions in Patients Undergoing Hemodialysis Sufferers undergoing maintenance hemodialysis have a increased risk of premature cardiovascular disease greatly.1,2 However, the design of coronary disease in such sufferers differs from that in the overall people, and although the risk of myocardial infarction is increased, other cardiovascular occasions, such as sudden cardiac center and death failure, predominate.